ALS2 p.Gly668Ter
c.2002G>T · rs730882255 · VCV183239
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | nonsense (stop-gain) | predicted loss-of-function |
|---|---|---|
| NMD | predicted | premature termination codon in exon 10 of 34 |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 1.7, phastCons 1 |
| Overall | ||
| CADD | 37.0 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- ALS2
- Protein
- p.Gly668Ter
- Coding
- c.2002G>T
- MANE Select
- NM_020919
- dbSNP
- rs730882255
- Type
- single nucleotide variant
- Location
- chr2:201744426 (GRCh38)
- Gene constraint
- LOEUF 0.649 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 74.69
Disease context
amyotrophic lateral sclerosis type 2, juvenile — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Juvenile amyotrophic lateral sclerosis (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood
- Prevalence
- <1 / 1 000 000 (Europe)
Similar variants
- ALS2 p.Gly668= Likely benign ★★ same residue
- ALS2 c.2580+2T>C Pathogenic ★★ same condition
- ALS2 c.4626+1G>A Pathogenic/Likely pathogenic ★★ same condition
- ALS2 p.Ala573Glu Likely pathogenic ★★ same condition
- ALS2 p.Arg1139Ter Pathogenic/Likely pathogenic ★★ same condition
- ALS2 p.Arg1421Ter Pathogenic/Likely pathogenic ★★ same condition
- ALS2 p.Arg1461Ter Pathogenic ★★ same condition
- ALS2 p.Arg201Ter Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/als2-p-gly668ter (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown